COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,280 Articles (22,759 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 1290: Articles 12891-12900  | Next

COVID-19 mitigation measures in primary schools and association with infection and school staff wellbeing: an observational survey linked with routine data in Wales, UK
Marchant, E., Griffiths, L., Crick, T., Fry, R., Hollinghurst, J., James, M., Cowley, L., Abbasizanjani, H., Torabi, F., Thompson, D., Kennedy, J., Akbari, A., Gravenor, M., Lyons, R. A., Brophy, S.
10.1101/2021.08.20.21262349 — Posted: 2021-08-24
Presence and Stability of SARS-CoV-2 on Environmental Currency and Money Cards
Newey, C., Olausson, A. T., Applegate, A., Reid, A. A., Robison, R. A., Grose, J. H.
10.1101/2021.08.23.457328 — Posted: 2021-08-23
Deep immune profiling of the maternal-fetal interface with mild SARS-CoV-2 infection
Sureshchandra, S., Zulu, M. Z., Doratt, B., Jankeel, A., Tifrea, D., Edwards, R. A., Rincon, M., Marshall, N. E., Messaoudi, I.
10.1101/2021.08.23.457408 — Posted: 2021-08-23
Intra-host SARS-CoV-2 evolution in the gut of mucosally-infected Chlorocebus aethiops (African green monkeys)
Rowe, L. A., Beddingfield, B. J., Goff, K., Killeen, S. Z., Chirichella, N. R., Melton, A., ROY, C. J., Maness, N. J.
10.1101/2021.08.22.457295 — Posted: 2021-08-23
mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern
Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., Gouma, S., Kuri-Cervantes, L., Hicks, P., Dysinger, S., Hicks, A., Sharma, H., Herring, S., Korte, S., Baxter, A. E., Oldridge, D. A., Giles, J. R., Weirick, M. E., McAllister, C. M., Awofolaju, M., Tanenbaum, N., Drapeau, E. M., Dougherty, J., Long, S., D'Andrea, K., Hamilton, J. T., McLaughlin, M., Williams, J. C., Adamski, S., The UPenn COVID Processing Unit, , Kuthuru, O., Frank, I., Betts, M. R., Vella, L. A., Grifoni, A., Weiskopf, D., Sette, A., Hensley, S. E., Davenport, M. P., Bates, P., Luning Prak, E. T., Greenplate, A. R., Wherry, E. J.
10.1101/2021.08.23.457229 — Posted: 2021-08-23
Induction of soluble platelet activation markers and FXIII deficiency promote COVID-19 severity
Al-Tamimi, A. O., Yusuf, A. M., Jayakumar, M. N., Ansari, A. W., Elhassan, M., AbdulKarim, F., Kannan, M., Halwani, R., Ahmad, F.
10.1101/2021.08.23.457378 — Posted: 2021-08-23
EFFECT OF EARLY TREATMENT WITH FLUVOXAMINE ON RISK OF EMERGENCY CARE AND HOSPITALIZATION AMONG PATIENTS WITH COVID-19: THE TOGETHER RANDOMIZED PLATFORM CLINICAL TRIAL
TOGETHER Trial, , Reis, G., Silva, E., Silva, D., Thabane, L., Milagres, A., Ferreira, T., dos Santos, C., Neto, A., Callegari, E., Savassi, L., Campos, V., Simplicio, M., Ribeiro, L., Oliveira, R., Harari, O., Forrest, J., Hinda, R., Sprague, S., McKay, P., Glushchenko, A., Rayner, C., Lenze, E., Reierson, A., Guyatt, G., Mills, E.
10.1101/2021.08.19.21262323 — Posted: 2021-08-23 Discussion: Onsite
Switching of OAS1 splicing isoforms mitigates SARS-CoV-2 infection
Iida, K., Ajiro, M., Muramoto, Y., Takenaga, T., Denawa, M., Kurosawa, R., Noda, T., Hagiwara, M.
10.1101/2021.08.23.457314 — Posted: 2021-08-23
The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines
Liu, Y., Arase, N., Kishikawa, J.-i., Hirose, M., Li, S., Tada, A., Matsuoka, S., Arakawa, A., Akamatsu, K., Ono, C., Jin, H., Kishida, K., Nakai, W., Kohyama, M., Nakagawa, A., Yamagishi, Y., Nakagami, H., Kumanogoh, A., Matsuura, Y., Standley, D. M., Kato, T., Okada, M., Fujimoto, M., Arase, H.
10.1101/2021.08.22.457114 — Posted: 2021-08-23 Discussion: Onsite | Offsite
Population birth outcomes in 2020 and experiences of expectant mothers during the COVID-19 pandemic: a Born in Wales mixed methods study using routine data
Jones, H., Seaborne, M., Cowley, L., Odd, D. E., Paranjothy, S., Akbari, A., Brophy, S.
10.1101/2021.08.23.21262209 — Posted: 2021-08-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).